What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Mary B. Daly mainly investigates Breast cancer, Cancer, Internal medicine, Oncology and Gynecology.
His study in Breast cancer is interdisciplinary in nature, drawing from both Odds ratio, Case-control study, Single-nucleotide polymorphism, Family history and Risk factor.
His studies in Cancer integrate themes in fields like Family medicine, Germline mutation, Epidemiology and Genetic testing.
His Internal medicine research incorporates elements of Gastroenterology and Cowden syndrome.
His work deals with themes such as BRCA2 Protein, Li–Fraumeni syndrome, Gene mutation, Epidemiology of cancer and Triple-negative breast cancer, which intersect with Oncology.
The study incorporates disciplines such as Oophorectomy, Prophylactic Oophorectomy, Ovarian cancer, Bilateral Prophylactic Oophorectomy and Hazard ratio in addition to Gynecology.
His most cited work include:
- Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations (1244 citations)
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality (965 citations)
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group (881 citations)
What are the main themes of his work throughout his whole career to date?
Mary B. Daly mostly deals with Breast cancer, Internal medicine, Oncology, Cancer and Ovarian cancer.
His Breast cancer study also includes fields such as
- Gynecology and related Obstetrics,
- Cohort study most often made with reference to Prospective cohort study.
His Internal medicine research focuses on subjects like Germline mutation, which are linked to Germline.
His research in Oncology intersects with topics in Retrospective cohort study, Mutation, Tamoxifen, Estrogen receptor and Prostate cancer.
His study focuses on the intersection of Cancer and fields such as Cancer research with connections in the field of Genotype.
Mary B. Daly does research in Ovarian cancer, focusing on Prophylactic Oophorectomy specifically.
He most often published in these fields:
- Breast cancer (56.45%)
- Internal medicine (39.86%)
- Oncology (35.48%)
What were the highlights of his more recent work (between 2018-2021)?
- Breast cancer (56.45%)
- Internal medicine (39.86%)
- Oncology (35.48%)
In recent papers he was focusing on the following fields of study:
Mary B. Daly spends much of his time researching Breast cancer, Internal medicine, Oncology, Prospective cohort study and Cancer.
His work carried out in the field of Breast cancer brings together such families of science as Cohort study, Mutation, Hazard ratio, Cohort and Risk factor.
His Internal medicine study which covers CHEK2 that intersects with DNA damage, Cancer risk assessment, Triple-negative breast cancer and FANCM.
His studies deal with areas such as Germline mutation, Ovarian cancer, Single-nucleotide polymorphism, Prostate cancer and Genetic testing as well as Oncology.
While the research belongs to areas of Prospective cohort study, Mary B. Daly spends his time largely on the problem of BRCA2 Mutation, intersecting his research to questions surrounding Obstetrics, breakpoint cluster region, Menopause and Surgical oncology.
His studies examine the connections between Cancer and genetics, as well as such issues in Reproductive health, with regards to Quality of life.
Between 2018 and 2021, his most popular works were:
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
- Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 1.2020 featured updates to the NCCN guidelines (94 citations)
- 10-year performance of four models of breast cancer risk: a validation study. (51 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His scientific interests lie mostly in Breast cancer, Internal medicine, Oncology, Prospective cohort study and Cohort.
Mary B. Daly interconnects Genome-wide association study, Family medicine, Medical genetics, Hazard ratio and Risk factor in the investigation of issues within Breast cancer.
As a member of one scientific family, he mostly works in the field of Family medicine, focusing on Vaginal dryness and, on occasion, Cancer.
His Oncology research is multidisciplinary, incorporating elements of Germline mutation, Ovarian cancer, Prostate cancer and Genetic testing.
The various areas that Mary B. Daly examines in his Prospective cohort study study include Incidence, Cohort study and Family history.
In his research on the topic of Cohort, Body mass index is strongly related with BRCA mutation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
